Hopson Ricky's most recent trade in Catalent Inc. was a trade of 662 Common Stock done at an average price of $59.6 . Disclosure was reported to the exchange on Aug. 2, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Catalent Inc. | Ricky Hopson | Pres. BioProduct Delivery, CoS | Sale of securities on an exchange or to another person at price $ 59.56 per share. | 02 Aug 2024 | 662 | 29,974 (0%) | 0% | 59.6 | 39,429 | Common Stock |
| Catalent Inc. | Ricky Hopson | Pres. BioProduct Delivery, CoS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2024 | 10,225 | 30,842 (0%) | 0% | 0 | Common Stock | |
| Catalent Inc. | Ricky Hopson | Pres. BioProduct Delivery, CoS | Sale of securities on an exchange or to another person at price $ 58.67 per share. | 26 Jul 2024 | 206 | 30,636 (0%) | 0% | 58.7 | 12,086 | Common Stock |
| Catalent Inc. | Ricky Hopson | Pres. BioProduct Delivery, CoS | Sale of securities on an exchange or to another person at price $ 54.26 per share. | 04 Jun 2024 | 1,401 | 20,617 (0%) | 0% | 54.3 | 76,023 | Common Stock |
| Catalent Inc. | Hopson Ricky | Pres. Clinical Dev Supply Div | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2023 | 747 | 22,274 (0%) | 0% | 0 | Common Stock | |
| Catalent Inc. | Hopson Ricky | Pres. Clinical Dev Supply Div | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.18 per share. | 08 Dec 2023 | 256 | 22,018 (0%) | 0% | 37.2 | 9,518 | Common Stock |
| Catalent Inc. | Ricky Hopson | Pres. Clinical Dev Supply Div | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 789 | 21,836 (0%) | 0% | 0 | Common Stock | |
| Catalent Inc. | Hopson Ricky | Pres. Clinical Dev Supply Div | Other type of transaction at price $ 0.00 per share. | 23 Aug 2023 | 789 | 21,251 (0%) | 0% | 0 | Common Stock | |
| Catalent Inc. | Ricky Hopson | Pres. Clinical Dev Supply Div | Sale of securities on an exchange or to another person at price $ 44.56 per share. | 23 Aug 2023 | 276 | 22,040 (0%) | 0% | 44.6 | 12,299 | Common Stock |
| Catalent Inc. | Ricky Hopson | Pres. Clinical Dev Supply Div | Other type of transaction at price $ 0.00 per share. | 23 Aug 2023 | 276 | 21,527 (0%) | 0% | - | Common Stock | |
| Catalent Inc. | Ricky Hopson | Pres. Clinical Dev Supply Div | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2023 | 10,669 | 10,669 | - | - | Options to purchase Common Stock | |
| Catalent Inc. | Ricky Hopson | Pres. Clinical Dev Supply Div | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2023 | 4,790 | 21,047 (0%) | 0% | 0 | Common Stock | |
| Catalent Inc. | Ricky Hopson | Pres. Clinical Dev Supply Div | Sale of securities on an exchange or to another person at price $ 47.86 per share. | 01 Aug 2023 | 195 | 16,257 (0%) | 0% | 47.9 | 9,333 | Common Stock |
| Catalent Inc. | Ricky Hopson | Pres. Clinical Dev Supply Div | Sale of securities on an exchange or to another person at price $ 49.36 per share. | 23 Jan 2023 | 643 | 16,452 (0%) | 0% | 49.4 | 31,738 | Common Stock |
| Catalent Inc. | Ricky Hopson | Pres. Clinical Dev Supply Div | Sale of securities on an exchange or to another person at price $ 89.59 per share. | 31 Aug 2022 | 2,216 | 17,095 (0%) | 0% | 89.6 | 198,531 | Common Stock |
| Catalent Inc. | Ricky Hopson | Pres. Clinical Dev Supply Div | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Aug 2022 | 3,733 | 20,828 (0%) | 0% | 0 | Common Stock | |
| Catalent Inc. | Ricky Hopson | Pres. Clinical Dev Supply Div | Sale of securities on an exchange or to another person at price $ 103.04 per share. | 24 Aug 2022 | 1,517 | 19,311 (0%) | 0% | 103.0 | 156,312 | Common Stock |
| Catalent Inc. | Ricky Hopson | Pres, Clinical Dev & Supply | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2022 | 2,828 | 2,828 | - | - | Options to purchase Common Stock | |
| Catalent Inc. | Ricky Hopson | Pres, Clinical Dev & Supply | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2022 | 651 | 17,686 (0%) | 0% | 0 | Common Stock | |
| Catalent Inc. | Ricky Hopson | Pres, Clinical Dev & Supply | Sale of securities on an exchange or to another person at price $ 107.67 per share. | 26 Jul 2022 | 591 | 17,095 (0%) | 0% | 107.7 | 63,633 | Common Stock |
| Catalent Inc. | Ricky Hopson | Pres, Clinical Dev & Supply | Sale of securities on an exchange or to another person at price $ 106.90 per share. | 26 Jul 2022 | 312 | 17,035 (0%) | 0% | 106.9 | 33,353 | Common Stock |
| Catalent Inc. | Ricky Hopson | VP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 103.39 per share. | 31 Jan 2022 | 2,325 | 17,073 (0%) | 0% | 103.4 | 240,382 | Common Stock |
| Catalent Inc. | Ricky Hopson | VP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 4,317 | 20,869 (0%) | 0% | 0 | Common Stock | |
| Catalent Inc. | Ricky Hopson | VP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 131.20 per share. | 26 Aug 2021 | 1,360 | 19,398 (0%) | 0% | 131.2 | 178,432 | Common Stock |
| Catalent Inc. | Ricky Hopson | VP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 130.29 per share. | 26 Aug 2021 | 111 | 20,758 (0%) | 0% | 130.3 | 14,462 | Common Stock |
| Catalent Inc. | Ricky Hopson | VP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2021 | 2,565 | 2,565 | - | - | Options to purchase Common Stock | |
| Catalent Inc. | Ricky Hopson | VP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2021 | 496 | 16,552 (0%) | 0% | 0 | Common Stock | |
| Catalent Inc. | Ricky Hopson | VP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 113.05 per share. | 26 Jul 2021 | 360 | 16,056 (0%) | 0% | 113.1 | 40,698 | Common Stock |
| Catalent Inc. | Ricky Hopson | VP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 3,432 | 16,325 (0%) | 0% | 0 | Common Stock |